Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRA | P10827 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | TLR2 | O60603 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | SIRT2 | Q8IXJ6 | 2/20 | 0.37 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.36 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25232569 | 0.94 | THRA (0.40) | THRATHRBDNM1EPHX2LMNA | |
| SCHEMBL31245911 | 0.94 | THRA (0.45) | THRATHRBDNM1EPHX2MAPT | |
| SCHEMBL31245868 | 0.94 | THRA (0.47) | THRATHRBDNM1EPHX2MAPT | |
| SCHEMBL25233267 | 0.92 | THRA (0.40) | THRATHRBDNM1EPHX2ALDH1A1 | |
| SCHEMBL31245860 | 0.92 | EPHX2 (0.43) | THRATHRBDNM1EPHX2MAPT | |
| SCHEMBL31245966 | 0.91 | THRB (0.40) | THRATHRBDNM1EPHX2MAPT | |
| SCHEMBL31245863 | 0.90 | DNM1 (0.51) | THRATHRBDNM1EPHX2MAPT | |
| SCHEMBL24849949 | 0.90 | EPHX2 (0.44) | THRATHRBEPHX2MAPTTLR2 | |
| SCHEMBL24849941 | 0.90 | EPHX2 (0.44) | THRATHRBEPHX2MAPTTLR2 | |
| SCHEMBL22767784 | 0.90 | EPHX2 (0.44) | THRATHRBEPHX2MAPTTLR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4687854-A2 | LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY | Flagship Labs 114, Inc. (US) | 2026-02-11 | — | — | EP | disclosed |
| WO-2024211865-A2 | LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY | OMEGA THERAPEUTICS, INC. (US) | 2024-10-10 | — | — | WO | disclosed |